The latest board meeting for Tscan Therapeutics Inc took place on 13 May 2025, for the purpose of TScan Therapeutics Inc First Quarter Earnings Results for 2025See details
Tscan Therapeutics Inc has a share price target of US$ 9, revenue growth forecast of 108.5%, and profit growth estimate of -15.6% for FY25, based on top 8 analyst calls.